Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Checking up on Dr. J B Matson's research site ... what's new
View:
Post by MrMugsy on Dec 15, 2020 12:09pm

Checking up on Dr. J B Matson's research site ... what's new

Further investigating Dr. John B Matson for updates.
Didn't realize the work also being done in COS ... newly added ... or me just not paying attention.  Possibly the latter.
COS = Carbonyl Sulphide

More on COS ...
https://www.liebertpub.com/doi/10.1089/ars.2017.7119

---------------

WELCOME to the Matson group website. We develop new small molecules and materials for biology, medicine, and sustainability using techniques and tools from organic chemistry, polymer chemistry, and supramolecular chemistry. Our research group is interdisciplinary, using chemistry to answer biological questions, discover potential new therapeutics, explore new polymer topologies, and design sustainable materials for a broad variety of applications. Current areas of focus include:

  • New compounds and materials for gasotransmitter delivery, focused on H2S and COS
  • Photo- and biodegradable polymer synthesis
  • Peptide-based responsive materials
  • New methods for synthesis of bottlebrush polymers
  • Novel covalent nanostructures with anisotropic shapes
Comment by MrMugsy on Dec 15, 2020 12:35pm
The part of the above link that really caught my eye ...  "Building on these factors, this review focuses on current knowledge of biological COS formation and consumption, growing evidence that COS may play roles in sulfide transport and disease pathology, emerging chemical tools for investigating COS in biological contexts, and the potential role of COS as a new member of the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities